Bond Charles Schwab & Co. 6.375% ( US80851QDA94 ) in USD

Issuer Charles Schwab & Co.
Market price 100 %  ⇌ 
Country  United States
ISIN code  US80851QDA94 ( in USD )
Interest rate 6.375% per year ( payment 2 times a year)
Maturity 01/09/2017 - Bond has expired



Prospectus brochure of the bond Charles Schwab US80851QDA94 in USD 6.375%, expired


Minimal amount 2 000 USD
Total amount 250 000 000 USD
Cusip 80851QDA9
Standard & Poor's ( S&P ) rating A ( Upper medium grade - Investment-grade )
Moody's rating A2 ( Upper medium grade - Investment-grade )
Detailed description Charles Schwab Corporation is a diversified financial services company offering brokerage, banking, and investment advisory services.

The Bond issued by Charles Schwab & Co. ( United States ) , in USD, with the ISIN code US80851QDA94, pays a coupon of 6.375% per year.
The coupons are paid 2 times per year and the Bond maturity is 01/09/2017

The Bond issued by Charles Schwab & Co. ( United States ) , in USD, with the ISIN code US80851QDA94, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency.

The Bond issued by Charles Schwab & Co. ( United States ) , in USD, with the ISIN code US80851QDA94, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency.







424B5
424B5 1 d424b5.htm 424B5
Table of Contents
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-36410
PRICING SUPPLEMENT
(To Prospectus dated May 19, 2000 and
Prospectus Supplement dated May 19, 2000)


$250,000,000
The Charles Schwab Corporation
Medium-Term Notes, Series A
6.375% Senior Notes due 2017

The Charles Schwab Corporation ("CSC") will offer $250,000,000 of 6.375% Senior Notes due 2017, which CSC
refers to in this pricing supplement as the "notes." Capitalized terms used in this pricing supplement that are
defined in the accompanying prospectus supplement or prospectus shall have the meanings assigned to them in the
prospectus supplement or prospectus.
The notes will mature on September 1, 2017. The notes will pay interest at 6.375% per annum. Interest on the
notes will be paid each March 1 and September 1, beginning on March 1, 2008. The notes will be senior unsecured
obligations of CSC, ranking equally with all of CSC's other unsecured senior indebtedness. The notes cannot be
redeemed prior to maturity.
CSC does not intend to apply for listing of the notes on any securities exchange.
Investing in the notes involves risk. See " Risk Factors" beginning on page PS-6.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or
disapproved of these notes or passed upon the accuracy or adequacy of this pricing supplement or the
accompanying prospectus supplement and prospectus. Any representation to the contrary is a criminal
offense.
These notes are not insured by the Federal Deposit Insurance Corporation or any other governmental agency.
These notes are not savings accounts, deposits or other obligations of any bank.

http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (1 of 124)9/18/2007 5:51:02 AM


424B5
Agent's
Price to
Discount or
Proceeds to


Public(1)

Commission
CSC
Per note

99.719%
0.65%
99.069%
Total

$249,297,500 $1,625,000 $247,672,500
(1) Plus accrued interest from September 14, 2007 if settlement occurs after that date.
The agents expect to deliver the notes in book-entry form only through the facilities of The Depository Trust
Company, for the accounts of its participants, including Clearstream Banking, société anonyme, Luxembourg and/
or Euroclear Bank S.A./N.V., against payment in New York, New York on or about September 14, 2007.
The agents are acting as underwriters in this offering of notes.
Agents
UBS Investment Bank
JPMorgan

September 11, 2007
http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (2 of 124)9/18/2007 5:51:02 AM


424B5
Table of Contents

TABLE OF CONTENTS



Page
Pricing Supplement

About this Pricing Supplement

PS-ii
Where You Can Find More Information

PS-iii
Forward-looking Statements

PS-1
Summary

PS-3
Risk Factors

PS-6
Use of Proceeds

PS-8
Capitalization

PS-9
Consolidated Ratios of Earnings to Fixed Charges

PS-10
Selected Consolidated Unaudited Pro Forma Financial Information

PS-11
Description of The Notes

PS-15
The Depositary

PS-17
Certain United States Federal Tax Consequences

PS-20
Certain ERISA Considerations

PS-23
Plan of Distribution

PS-25
Legal Matters

PS-27


Page
Prospectus Supplement

Summary

S-3
Description of Notes

S-4
The Depositary

S-18
United States Federal Taxation

S-19
Plan of Distribution

S-25
Legal Matters

S-26
Prospectus

The Charles Schwab Corporation

3
Consolidated Ratio of Earnings to Fixed Charges

3
Use of Proceeds

3
Description of Debt Securities

4
http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (3 of 124)9/18/2007 5:51:02 AM


424B5
Plan of Distribution

11
Legal Matters

13
Experts

13

PS-i
http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (4 of 124)9/18/2007 5:51:02 AM


424B5
Table of Contents

About this pricing supplement
This document consists of three parts. The first part is the pricing supplement, which describes the price per note,
interest rate, maturity date and aggregate principal amount of this offering. The second part is the prospectus
supplement, which describes the specific terms of the medium-term notes. The third part is the prospectus, which
describes more general information, some of which may not apply to this offering. You should read this pricing
supplement and the accompanying prospectus supplement and prospectus, together with additional information
described under the heading "Where You Can Find More Information" in this pricing supplement.
References in this pricing supplement to "CSC" mean The Charles Schwab Corporation.
If the information set forth in this pricing supplement differs in any way from the information set forth in the
accompanying prospectus supplement and prospectus, you should rely on the information set forth in this pricing
supplement.
You should rely only on the information contained in or incorporated by reference in this pricing supplement, the
accompanying prospectus supplement and prospectus and any free writing prospectus relating to the notes issued
hereby prepared by or on behalf of CSC at the time of pricing. No one is authorized to give information other than
that contained herein and therein. This pricing supplement may be used only for the purpose for which it has been
prepared. CSC has not, and the agents have not, authorized any other person to provide you with different
information. If anyone provides you with different or inconsistent information, you should not rely on it.
The representations, warranties and covenants made by CSC in any agreement that is filed as an exhibit to any
document that is incorporated by reference in this pricing supplement and the accompanying prospectus
supplement and prospectus were made solely for the benefit of the parties to such agreement, including, in some
cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a
representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were
accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not
be relied on as accurately representing the current state of CSC's affairs.
CSC is not, and the agents are not, making an offer to sell these notes in any jurisdiction where the offer or sale is
not permitted. You should not assume that the information appearing in this pricing supplement, the
accompanying prospectus supplement and prospectus or any document incorporated by reference is accurate as of
any date other than the date of the applicable document. CSC's business, financial condition, results of operations
and prospects may have changed since that date. Neither this pricing supplement nor the accompanying prospectus
supplement and prospectus constitutes an offer, or an invitation on CSC's behalf or on behalf of the agents, to
subscribe for and purchase, any of the notes and may not be used for or in connection with an offer or solicitation
by anyone, in any jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is
unlawful to make such an offer or solicitation.
http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (5 of 124)9/18/2007 5:51:02 AM


424B5
The agents are acting as underwriters in this offering of notes.
PS-ii
http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (6 of 124)9/18/2007 5:51:02 AM


424B5
Table of Contents

Where you can find more information
CSC files annual, quarterly and current reports, proxy statements and other information with the Securities and
Exchange Commission (the "SEC"). CSC's SEC filings are available to the public over the Internet at the SEC's
website at http://www.sec.gov. Copies of certain information filed by CSC with the SEC are also available on
CSC's corporate website at http://www.aboutschwab.com. This website is not a part of this pricing supplement or
the accompanying prospectus supplement and prospectus. You may also read and copy any document that CSC
files at the SEC's Public Reference Room, 450 Fifth Street, N.W., Washington, D.C. 20549. You may obtain
information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.
The SEC allows CSC to "incorporate by reference" information CSC has filed with the SEC, which means that
CSC can disclose important information to you by referring you to other documents. The information incorporated
by reference is considered to be a part of this pricing supplement.
This pricing supplement incorporates by reference the documents listed below:

Ø Annual Report on Form 10-K for the fiscal year ended December 31, 2006 (including such information from
the Proxy Statement filed March 30, 2007 that is incorporated by reference in Part III of such Annual Report),
as updated by CSC's Form 8-K filed on July 17, 2007 relating to CSC's realigned segment reporting structure;

Ø Quarterly Reports on Form 10-Q for the quarters ended March 31, 2007 and June 30, 2007; and

Ø Current Reports on Form 8-K filed on January 26, 2007, February 23, 2007, April 10, 2007, April 27,
2007, May 21, 2007, July 3, 2007, July 17, 2007 (relating to CSC's realigned segment reporting structure) and
September 11, 2007.
You may request a copy of these filings at no cost, by writing, telephoning or sending an email to the following
address:
The Charles Schwab Corporation
101 Montgomery Street
San Francisco, California 94104
Attention: Corporate Secretary
Telephone: (415) 627-7000
Email: [email protected]

PS-iii
http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (7 of 124)9/18/2007 5:51:02 AM


424B5
Table of Contents

Forward-looking statements
This pricing supplement and the accompanying prospectus supplement and prospectus, including the documents
incorporated by reference, contain not only historical information but also forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements are identified by
words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may", "estimate", "aim", "target",
"could", "would", "should", "continue", "potentially" and other similar expressions. These statements, which may
be expressed in a variety of ways, including the use of future or present tense language, refer to future events. In
addition, any statements that refer to expectations, projections or other characterizations of future events or
circumstances are forward-looking statements.
These forward-looking statements, which reflect management's beliefs, objectives and expectations as of the date
hereof, or in the case of any documents incorporated by reference, as of the date of those documents, are
necessarily estimates based on the best judgment of CSC's senior management. These statements relate to, among
other things:

Ø CSC's ability to service CSC's debt, fund future dividends and capital requirements and have appropriate
financial flexibility for general corporate purposes from CSC's cash balances, anticipated cash flows from
operations and borrowing capacity;

Ø CSC's expected offering of hybrid capital securities in connection with CSC's capital restructuring, including
the amount, timing and terms of such issuances;

Ø the use of proceeds from this debt offering;

Ø a trading market for the notes;

Ø the incurrence of additional debt by CSC;

Ø the tax treatment of the notes;

Ø CSC's ability to pursue its business strategy;

Ø the impact of changes in unrecognized tax benefits on CSC's results of operations;

Ø the impact of changes in the likelihood of indemnification payment obligations on CSC's results of operations;

Ø the impact of changes in estimated costs related to past restructuring initiatives on CSC's results of operations;

Ø the impact of legal proceedings and regulatory matters;

Ø the impact of changes in the income tax benefit related to the sale of U.S. Trust Corporation ("U.S. Trust");

Ø sources of liquidity, capital and level of dividends;

http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (8 of 124)9/18/2007 5:51:02 AM


424B5
Ø the timing and amount of capital expenditures;

Ø target capital ratios; and

Ø the other risks and uncertainties described in this pricing supplement.
Achievement of the expressed beliefs, objectives and expectations described in these statements is subject to
certain risks and uncertainties that could cause actual results to differ materially from the expressed

PS-1
http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (9 of 124)9/18/2007 5:51:02 AM


424B5
Table of Contents
Forward-looking statements
beliefs, objectives and expectations. Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this pricing supplement or, in the case of documents incorporated by
reference, as of the date of those documents.
Important factors that may cause actual results to differ include, but are not limited to:

Ø unanticipated changes in the amounts of CSC's cash balances, cash flows from CSC's operations and/or
borrowing capacity;

Ø market conditions, including the demand for new hybrid capital issues;

Ø changes in general economic and financial market conditions;

Ø changes in interest rates;

Ø the level of CSC's stock repurchase activity;

Ø changes in the competitive environment, including price competition and continued consolidation in the
financial services industry;

Ø unanticipated adverse developments in litigation or regulatory matters;

Ø CSC's ability to sublease certain properties;

Ø the amount of loans to CSC's banking and brokerage clients;

Ø the timing and impact of changes in CSC's level of investments in technology;

Ø changes in CSC's level of personnel;

Ø potential breaches of contractual terms for which CSC has indemnification obligations;

Ø changes in the income tax benefit based on the results of a tax survey related to the sale of U.S. Trust;

Ø the timing and impact of the settlement of tax audits;

Ø the timing and impact of strategic transactions;

Ø changes in unrecognized tax benefits on CSC's results of operations;

Ø changes in estimated costs related to past restructuring initiatives on CSC's results of operations;

Ø changes in legislation or rules and regulations which affect CSC's business and/or the hybrid capital securities;

Ø CSC's ability to maintain favorable ratings from rating agencies;

Ø effects of critical accounting policies and judgments;

Ø changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board
or other regulatory agencies; and
http://www.sec.gov/Archives/edgar/data/316709/000119312507199788/d424b5.htm (10 of 124)9/18/2007 5:51:02 AM


Document Outline